Alzheimers Dement

1. YU L, Yokomizo S, Doan TH, Zhao Q, et al
   Zolpidem restores sleep and decreases amyloid in a mouse model.
   Alzheimers Dement. 2026;22:e71175.
   

   >> Share

   
   
2. BIBER S, Culhane JE, Prado MG, Mathew S, et al
   Integrating real-world data with gold-standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof-of-concept data platform.
   Alzheimers Dement. 2026;22:e71207.
   

   >> Share

   
   
3. KIM JP, Song M, Cho M, Lee H, et al
   Genetic architecture of plasma pTau217 and related biomarkers in Alzheimer's disease via genome-wide association studies.
   Alzheimers Dement. 2026;22:e71275.
   

   >> Share

   
   
4. CHEN S, Hao X, Ma K, Li R, et al
   Implementing plasma p-tau217 and cognitive testing for Alzheimer's screening in low-education populations in central China.
   Alzheimers Dement. 2026;22:e71251.
   

   >> Share

   
   
5. MOHAMMEDIYAN B, Baril AA, Fajardo Valdez A, St-Onge F, et al
   Longitudinal association between sleep and Alzheimer's pathology.
   Alzheimers Dement. 2026;22:e71228.
   

   >> Share

   
   
6. HASAN Z, Torraville SE, Omoluabi T, Maziar A, et al
   Sex and life experience shape locus coeruleus pretangle tau pathology.
   Alzheimers Dement. 2026;22:e71285.
   

   >> Share

   
   
7. HALL S, Garcia L, Stahmer M, Griffin P, et al
   The Alzheimer's Association TrialMatch-Increasing awareness of all dementia trials.
   Alzheimers Dement. 2026;22:e71250.
   

   >> Share

   
   
8. WEARN A, Onuska KM, Schmitz TW, Turner GR, et al
   The neuromodulatory fragility hypothesis of Alzheimer's disease pathogenesis.
   Alzheimers Dement. 2026;22:e71249.
   

   >> Share

   
   
9. CICERO EC, Flatt JD, Kaabi O, Tangpricha V, et al
   Alzheimer's disease and related dementias among transfeminine adults: A cohort study.
   Alzheimers Dement. 2026;22:e71277.
   

   >> Share

   
   
10. LIM S, Lee J, Min PH, Moloney CM, et al
    Tau PET overlap index correlation with neuropathological findings.
    Alzheimers Dement. 2026;22:e71241.
    

    >> Share

    
    
11. ZHANG Y, Qian XH, Zhuang H, Zhang W, et al
    Dual association patterns between microglial activation and neuronal health in Alzheimer's disease: a whole-brain MRSI/PET study.
    Alzheimers Dement. 2026;22:e71229.
    

    >> Share

    
    
12. BUBU OM, Mullins AE, Shah S, Gills JL, et al
    Obstructive sleep apnea severity, Alzheimer's disease plasma markers, and CSF brain amyloidosis and tau pathology.
    Alzheimers Dement. 2026;22:e71270.
    

    >> Share

    
    
13. TEE BL, Spat-Lemus J, Zhang SX, Upendra S, et al
    Advancing global precision in dementia research: Examining Normative Heterogeneity of Aging and Neurodegeneration in Chinese Elders (ENHANCE).
    Alzheimers Dement. 2026;22:e71166.
    

    >> Share

    
    
14. HUSSAIN Z, Ng D, Leighton S, Deligianni F, et al
    Plasma inflammatory biomarker profiles across the Alzheimer's disease spectrum in the Bio-Hermes cohort.
    Alzheimers Dement. 2026;22:e71257.
    

    >> Share

    
    
15. MARIER A, Fernandez Arias J, Aumont E, Hall BJ, et al
    Language deficits across PET-based Braak stages of tau accumulation in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71286.
    

    >> Share

    
    
16. CHEUNG C, Anita NZ, Filigrana P, Fornage M, et al
    APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos.
    Alzheimers Dement. 2026;22:e71213.
    

    >> Share

    
    
17. KUMAR A, Ray NR, Kurup JT, Rosario PD, et al
    Genetic correlation analysis identifies TMEM106B, ACE, and ERC2 as genetic loci shared between Alzheimer's disease and primary psychiatric disorders.
    Alzheimers Dement. 2026;22:e71278.
    

    >> Share

    
    
18. FRONTERA JA, Masurkar AV, Betensky RA, Alvarez Z, et al
    Increased incidence of mild cognitive impairment in long COVID patients.
    Alzheimers Dement. 2026;22:e71237.
    

    >> Share

    
    
19. LIAO W, Yu Q, Chen B, Chen H, et al
    Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.
    Alzheimers Dement. 2026;22:e71231.
    

    >> Share

    
    

    
    Am J Alzheimers Dis Other Demen

20. CARLOZZI NE, Fansher M, Troost JP, Miner JA, et al
    Validating the Use of TBI-CareQOL Measures in Caregivers of People Living With Dementia.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261426872.
    

    >> Share

    
    

    
    Ann Neurol

21. IBANEZ L, Pottier C, Beric A, Western D, et al
    Understanding Neurodegenerative Diseases From the -Omics Perspective: Lessons Learnt.
    Ann Neurol. 2026;99:566-587.
    

    >> Share

    
    

    
    Biochemistry

22. DUTTA B, Loo S, Kam A, Liu CF, et al
    Targeted Protein Degrader from Ginkgo to Mitigate Amyloid beta-Induced Neurotoxicity.
    Biochemistry. 2026;65:545-558.
    

    >> Share

    
    

    
    BMC Geriatr

23. LU H, Chen S, Tang Y, He W, et al
    Sex differences in the associations between illness representations and behavioral intentions to seek early Alzheimer's detection in Chinese older adults.
    BMC Geriatr. 2026 Mar 10. doi: 10.1186/s12877-026-07288.
    

    >> Share

    
    

    
    BMC Neurol

24. KIENE F, Notbohm A, Roheger M, Duning T, et al
    Cognitive tests distinguish biomarker-verified early Alzheimer's disease from other patients.
    BMC Neurol. 2026 Mar 6. doi: 10.1186/s12883-026-04742.
    

    >> Share

    
    

    
    Brain Res

25. LI J, Wang C, Zhang JH, Cai JM, et al
    Retraction notice to "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [Brain Res. 1328 (2010) 152-161].
    Brain Res. 2026 Mar 6:150251. doi: 10.1016/j.brainres.2026.150251.
    

    >> Share

    
    

    
    Curr Opin Neurol

26. DAS S, Hyman BT, Serrano-Pozo A
    A critical appraisal of the link between apolipoprotein E and Tau.
    Curr Opin Neurol. 2026;39:200-209.
    

    >> Share

    
    

    
    Exp Gerontol

27. QIU D, Zhou S, Donnelly J, Xia D, et al
    Aerobic exercise attenuates abnormal myelination and oligodendrocyte differentiation in 3xTg-AD mice.
    Exp Gerontol. 2023;182:112293.
    

    >> Share

    
    

    
    Exp Neurol

28. ISLA AG, Balleza-Tapia H, Chu F, Chen G, et al
    Low dose of levetiracetam counteracts amyloid beta-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity.
    Exp Neurol. 2023;369:114545.
    

    >> Share

    
    
29. ZHANG SZ, Ma Y, Ding Y, Yin YQ, et al
    Astrocytic TPK1 mitigates amyloid pathology via TFEB-mediated endocytosis.
    Exp Neurol. 2026;398:115640.
    

    >> Share

    
    

    
    J Alzheimers Dis

30. SEJUNAITE K, Gaucher F, Lanza C, Riepe MW, et al
    Clock Drawing Test: Types of Errors and Accuracy in Early Cognitive Screening.
    J Alzheimers Dis. 2023;95:1597-1608.
    

    >> Share

    
    
31. ALAFUZOFF I, Libard S
    Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers.
    J Alzheimers Dis. 2026;110:397-408.
    

    >> Share

    
    
32. LINGLER JH
    Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters.
    J Alzheimers Dis. 2026;110:86-88.
    

    >> Share

    
    
33. ROS F, Martinez Lozano MD, Arnau J, Martinez J, et al
    Decreased interleukin-8 levels in the peripheral blood of Alzheimer's disease patients.
    J Alzheimers Dis. 2026 Mar 10:13872877261428052. doi: 10.1177/13872877261428052.
    

    >> Share

    
    
34. KE Z, Wang B, Liang R
    Modulation of mitochondrial quality by exercise mimetics: A potential strategy for the prevention and treatment of Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 10:13872877261424276. doi: 10.1177/13872877261424276.
    

    >> Share

    
    
35. LIU R, Qi X, Luo H, Liu Y, et al
    Edentulism and risk of all-cause dementia and Alzheimer's disease: A competing risk analysis by cognitive status.
    J Alzheimers Dis. 2026 Mar 10:13872877261424215. doi: 10.1177/13872877261424215.
    

    >> Share

    
    
36. ZHOU H, Zhao X, Li Y, Wang Y, et al
    Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 mice.
    J Alzheimers Dis. 2026 Mar 10:13872877261422502. doi: 10.1177/13872877261422502.
    

    >> Share

    
    
37. ZHANG Y, Zhang D, Xiao H
    Regulated neuronal death in Alzheimer's disease: Crosstalk and convergence of apoptosis, pyroptosis, senescence, and ferroptosis.
    J Alzheimers Dis. 2026 Mar 11:13872877261430002. doi: 10.1177/13872877261430002.
    

    >> Share

    
    
38. LIU A, Xing L, Li J, Yao M, et al
    The interplay between mitophagy and ferroptosis in Alzheimer's disease: Mechanisms and therapeutic implications.
    J Alzheimers Dis. 2026 Mar 13:13872877261420211. doi: 10.1177/13872877261420211.
    

    >> Share

    
    
39. PENG T, Xu P, Guo X, Lin J, et al
    Integrated network toxicology and computational profiling of acetyl tributyl citrate-related mechanisms in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261423948. doi: 10.1177/13872877261423948.
    

    >> Share

    
    
40. LAVROVA A, Satoh R, Tosakulwong N, Weigand SD, et al
    FDG-PET imaging to identify brain regions associated with Alzheimer's disease-related TDP-43 proteinopathy: A predictive model using penalized logistic regression analysis.
    J Alzheimers Dis. 2026 Mar 13:13872877261421241. doi: 10.1177/13872877261421241.
    

    >> Share

    
    
41. WEI D, Dal H, Dalman C, Karlsson H, et al
    Association between arsenic exposure and the risk of Alzheimer's disease: A cohort study in Sweden.
    J Alzheimers Dis. 2026 Mar 13:13872877261427465. doi: 10.1177/13872877261427465.
    

    >> Share

    
    
42. FAUCHER C, Thienel R, Behler A, Gomez L, et al
    The relationship between napping and memory varies as a function of genetic risk for Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261427707. doi: 10.1177/13872877261427707.
    

    >> Share

    
    
43. ARIYATH A, Hone E, Fernando WMADB, Pedrini S, et al
    USP14 inhibitor IU1 alleviates amyloid-beta mediated toxicity in Alzheimer's disease cell and worm models.
    J Alzheimers Dis. 2026 Mar 13:13872877261422775. doi: 10.1177/13872877261422775.
    

    >> Share

    
    
44. ROCHAIS C, Lecoutey C, Culley G, Curel T, et al
    An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride.
    J Alzheimers Dis. 2026 Mar 13:13872877261424925. doi: 10.1177/13872877261424925.
    

    >> Share

    
    
45. HADA K, Murata Y, Ohi Y, Hashimoto S, et al
    Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists.
    J Alzheimers Dis. 2026;110:588-604.
    

    >> Share

    
    
46. YANG F, Xu B, Lin J, Zheng D, et al
    Early detection of Alzheimer's disease based on leveraging multimodal features of the clock drawing test.
    J Alzheimers Dis. 2026 Mar 12:13872877261423940. doi: 10.1177/13872877261423940.
    

    >> Share

    
    
47. REN Y, Saleem K, Patel PJ, Lee YH, et al
    Diminished activity-dependent neuroprotective protein (ADNP) contributes to complement gene elevation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 12:13872877261427770. doi: 10.1177/13872877261427770.
    

    >> Share

    
    
48. ALKAM T, Tarshizi E, Van Benschoten AH
    Detecting multimorbidity patterns in Alzheimer's disease using unsupervised machine learning: A nationwide emergency department study (2007-2022).
    J Alzheimers Dis. 2026 Mar 12:13872877261430952. doi: 10.1177/13872877261430952.
    

    >> Share

    
    
49. SCARAMUZZI GF, Manippa V, Taurisano P
    Re-tuning the brain: The promise of 40 Hz sensory stimulation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 12:13872877261429856. doi: 10.1177/13872877261429856.
    

    >> Share

    
    
50. YIRUN A, Cakir DA, Erdemli Kose SB, Ozyurt AB, et al
    Determination of the effects of Herpes simplex glycoprotein B on epigenetic alterations in in vitro models of Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261427784. doi: 10.1177/13872877261427784.
    

    >> Share

    
    
51. BOTCHWAY BOA, Kousiappa I, Koupparis A, Papacostas S, et al
    From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management.
    J Alzheimers Dis. 2026 Mar 13:13872877261428636. doi: 10.1177/13872877261428636.
    

    >> Share

    
    

    
    J Am Geriatr Soc

52. GUPTA R, Lin S, DiStefano MJ, Woo HYJ, et al
    Patient Preferences for Dementia Interventions: A Scoping Review With a Systematic Review of Medications and Choice-Based Methods.
    J Am Geriatr Soc. 2026;74:868-882.
    

    >> Share

    
    

    
    J Biol Chem

53. EALY A, Serapiglia AM, Panicker N
    Sterile innate immune mechanisms in neurodegenerative diseases.
    J Biol Chem. 2026;302:111039.
    

    >> Share

    
    
54. CRUCETA L, Sun Y, Kenyaga JM, Ostrovsky D, et al
    Modulation of aggregation and structural polymorphisms of beta-amyloid fibrils in cellular environments by pyroglutamate-3 variant cross-seeding.
    J Biol Chem. 2023;299:105196.
    

    >> Share

    
    

    
    J Neuropsychol

55. BRUNO D, Reichert-Plaska C, Jauregi-Zinkunegi A, Ashton NJ, et al
    Associations of plasma p-tau231 with serial position recall performance in free-of-dementia individuals.
    J Neuropsychol. 2026;20:291-300.
    

    >> Share

    
    

    
    J Neurosci

56. TERSTEGE DJ, Epp JR
    Environmental Enrichment Preserves Retrosplenial Parvalbumin Density and Cognitive Function in Female 5xFAD Mice.
    J Neurosci. 2026;46:e0455252026.
    

    >> Share

    
    

    
    JAMA

57. ANDERER S
    Alzheimer Disease Sex Differences May Be Tied to P-Tau217.
    JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1013.
    

    >> Share

    
    

    
    Nature

58. PICARD M, Kempes CP
    From cancer to Alzheimer's: could a renewed focus on energy transform biomedicine?
    Nature. 2026;651:303-305.
    

    >> Share

    
    

    
    Nervenarzt

59. BANG C, Heinzel S
    [Relationships between microbiome and neurodegeneration].
    Nervenarzt. 2023;94:885-891.
    

    >> Share

    
    

    
    Neurobiol Dis

60. LANOOIJ SD, Drinkenburg WHIM, Eisel ULM, van der Zee EA, et al
    The effects of social environment on AD-related pathology in hAPP-J20 mice and tau-P301L mice.
    Neurobiol Dis. 2023;187:106309.
    

    >> Share

    
    
61. JIANG Z, Saleem K, Fisher E, Li L, et al
    SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients.
    Neurobiol Dis. 2026;221:107345.
    

    >> Share

    
    

    
    Neurology

62. LORENZINI L, Tranfa M, Kate MT, Braber AD, et al
    CSF Proteomic Profiles Associated With White Matter Integrity in Cognitively Normal Older Adults With and Without Amyloid Pathology.
    Neurology. 2026;106:e214675.
    

    >> Share

    
    
63. CLARK AL, Asimakopoulos G, Valocchi E, Chanfreau-Coffinier C, et al
    Individual-Level Factors Associated With 10-Year Incidence of Alzheimer Disease and Related Dementias in the VA Million Veteran Program.
    Neurology. 2026;106:e214748.
    

    >> Share

    
    

    
    Neuroscience

64. SHEN X, Dong X, Nao J
    Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease.
    Neuroscience. 2026;601:155-168.
    

    >> Share

    
    
65. DENG LJ, Wu D, Yang XF, Li T, et al
    miR-146a-5p Modulates Adult Hippocampal Neurogenesis Deficits Through Klf4/p-Stat3 Signaling in APP/PS1 Mice.
    Neuroscience. 2023;526:314-325.
    

    >> Share

    
    

    
    PLoS Med

66. ARMSTRONG RA, Yousefi P, Gibbison B, Khandaker GM, et al
    The genetic architecture of postoperative delirium after major surgery and its relationship with nonpostoperative neurocognitive conditions: A genome-wide association study.
    PLoS Med. 2026;23:e1004963.
    

    >> Share

    
    

    
    PLoS One

67. BRADY JJR, Bartlett L, Roccati E, Norris K, et al
    Psychosocial hierarchies of modifiable risk for Alzheimer's disease: A networks analysis.
    PLoS One. 2026;21:e0333148.
    

    >> Share

    
    
68. MAO Z, Peng Y, Lin R, Guo X, et al
    Association of intraindividual differences in estimated glomerular filtration rates based on cystatin C and creatinine with dementia: A cohort study of the UK Biobank.
    PLoS One. 2026;21:e0344566.
    

    >> Share

    
    
69. HENAO ISAZA V, Aguillon D, Tobon-Quintero CA, Lopera F, et al
    Comprehensive methodology for sample enrichment in EEG biomarker studies for Alzheimer's risk classification.
    PLoS One. 2026;21:e0343722.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

70. JIANG Y, Zheng W, Xia Z, Wong WW, et al
    Head-to-head comparison of brain-derived pTau217 and total pTau217 for brain amyloid and tau pathology classification.
    Proc Natl Acad Sci U S A. 2026;123:e2536792123.
    

    >> Share

    
    

    
    Science

71. CHEN Y, Liu Y, Nguyen K, Wu J, et al
    Targeting amyloid-beta pathology by chimeric antigen receptor astrocyte (CAR-A) therapy.
    Science. 2026;391:eads3972.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share